Telomir Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 14 04:36 · Announcements

Telomir Pharmaceuticals Sees Breakthrough Potential in Anti-Aging Treatment With Telomir 1 | NASDAQ:TELO

Proactive InvestorsMay 7 22:52

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersPredictive Oncology (NASDAQ:POAI) shares rose 36.4% to $1.95 during Tuesday's after-market session. The company's market cap stands at $7.9 million. Brainstorm Cell (NASDAQ:BCLI) shares moved u

BenzingaMay 1 04:31

MRIN, WISA and SMFL Among Mid-day Movers

Seeking AlphaApr 23 00:52

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.

Telomir-1 elongates telomere caps on human normal embryonic fibroblast cells by stimulating the enzyme telomerase that protects the DNA and genetic material in chromosomes to combat aging Demonstrated a 40% increase in

GlobeNewswireApr 16 20:30

Telomir Pharmaceuticals Unveils Research Direction at NPC

TipRanksApr 16 04:35